A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the response rates for prostate cancer patients taking
chemotherapy plus enzastaurin versus chemotherapy plus placebo.